Dipna Pharmachem submits integrated financial statements to BSE

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹6.00

prior close

₹6.06

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+0.3% vs market

Pharmaceuticals peers, median of 165sector+0.2%-0.2% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

+3.1

15m

+3.1

30m

+2.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0-0.3+0.3+0.2-0.2

Next day

+0.0-0.1+0.1-0.3+0.3

-4.5-0.8-3.7-0.5-4.0

-6.3-2.8-3.5-1.2-5.1

+5.0-1.0+6.0-0.7+5.7

-3.2+0.4-3.6-0.1-3.1

-7.2-0.5-6.7+0.6-7.8

15d

-16.0-1.9-14.1-1.8-14.2

-17.8+0.4-18.3-0.5-17.3

-3.3+3.5-6.8+0.9-4.3

-28.7+2.0-30.7+0.4-29.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dipna Pharmachem Ltd has submitted its integrated financial statements to BSE. Integrated financials typically combine annual results, balance sheet, cash flow statement, and notes into a single compliance filing. The detailed financial figures and any auditor observations would be available in the attached document for investors to review.

Likely market impact

Routine compliance filing; no immediate price action expected unless figures show surprises.